Foley & Lardner LLP senior counsel Roberto Fernandez assessed new procedures at the U.S. Patent and Trademark Office (USPTO) in the Law360 article, “New Procedures Expected To Result In More PTAB Denials.”
Commenting on a memo from the acting USPTO director intended to address the Patent Trial and Appeal Board’s (PTAB) “workload needs,” Fernandez said “it’s almost as it that’s now a factor in the discretionary denial analysis, which previously didn’t exist.”
“I think what you’ll see is each of these bullet points fleshed out in short order,” and that will “lay the groundwork for future PTAB institution decisions,” he added.
(Subscription required)
People
Related News
January 6, 2026
In the News
Kyle Faget Weighs in on Pharmaceutical Industry Legal Battles
Foley & Lardner LLP partner Kyle Faget shared insight with Law360 on major legal topics affecting the pharmaceutical industry.
January 2, 2026
In the News
Judith Waltz Shares Insights on Key Health Law Developments on AHLA Podcast
Foley & Lardner LLP partner Judith Waltz hosted the American Health Law Association's Speaking of Health Law podcast to discuss major health law developments from 2025 and offer insights on trends expected in 2026.
January 2, 2026
In the News
Rajiv Dharnidharka Examines Trade Secret Litigation Trends
Foley & Lardner LLP partner Rajiv Dharnidharka commented on anticipated developments in trade secret law this year in the Law360 article, “Trade Secret Trends To Watch In 2026.”